ArticleJournal of endocrinological investigation2026
Diagnosis and management of polycystic ovary syndrome/polyendocrine metabolic ovarian syndrome: unmet needs and areas of clinical confidence among European endocrinologists.
Article in Journal of endocrinological investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPolycystic ovary syndrome (PCOS) or polyendocrine metabolic ovarian syndrome (PMOS) is a common, heterogeneous endocrine disorder whose diagnosis and management remain variable across clinical settings. Despite contemporary international guidance, several diagnostic definitions and therapeutic decisions are not consistently applied.
objectiveTo identify persistent unmet needs and areas of clinical confidence in PCOS/PMOS care, using the 2023 survey of the European Society of Endocrinology PCOS Special Interest Group as the principal data source.
methodsThis manuscript presents a secondary, survey-informed analysis of aggregate data from an electronic cross-sectional survey distributed to members of the European Society of Endocrinology. A total of 505 respondents participated. Survey findings were interpreted in the context of current guidelines, contemporary evidence, the previous 2014 European survey, and patient-reported priorities.
resultsConsiderable variation was observed in the operational definition of chronic ovulatory dysfunction, the assessment of hirsutism, the biochemical evaluation of androgen excess, and the interpretation of ovarian morphology. Only one quarter of respondents reported access to liquid chromatography-tandem mass spectrometry for steroid measurement. Uncertainty also persisted regarding the choice and duration of combined oral contraceptive therapy and the optimal pharmacological approach to chronic anovulation. Conversely, several areas of clinical confidence were evident. Respondents commonly assessed metabolic risk and lifestyle behaviours, recognized the psychological burden of PCOS/PMOS, emphasized lifestyle intervention, and supported multidisciplinary care. Physician priorities also showed increasing concordance with the concerns reported by women with PCOS/PMOS.
conclusionsPCOS/PMOS care in Europe combines important progress in patient-centered, metabolic, and multidisciplinary management with persistent diagnostic and therapeutic variability. Greater standardization of operational diagnostic definitions, wider access to accurate steroid assays, and adequately powered comparative trials of commonly used treatments are required. These initiatives should be developed alongside, rather than at the expense of, the patient-centered practices that are already well established. STUDY
designSecondary analysis and expert interpretation of cross-sectional survey data.
Indexed as
Identifiers
42905305What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.